Recent investigations into retatrutide, a dual agonist for GLP-1 and GIP receptors, are revealing encouraging effects in addressing excess mass and related non-insulin-dependent diabetes. Animal evidence suggest a https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/